DescriptionSources: https://www.hindawi.com/journals/stni/2014/839369/Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Sources: https://www.hindawi.com/journals/stni/2014/839369/
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:14:06 GMT 2023
by
admin
on
Sat Dec 16 00:14:06 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG1 |
Sequence Origin | MOUSE |
Sequence Type | COMPLETE |
Record UNII |
029JF1SCU8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
CEA-SCAN (WITHDRAWN: COLORECTAL NEOPLASMS)
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
||
|
WHO-ATC |
V09IA06
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Technetium (99mTc) arcitumomab
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | |||
|
230435
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | RxNorm | ||
|
029JF1SCU8
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | |||
|
m2034
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
154361-49-6
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | |||
|
DB00113
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL1743090
Created by
admin on Sat Dec 16 00:14:06 GMT 2023 , Edited by admin on Sat Dec 16 00:14:06 GMT 2023
|
PRIMARY |
Glycosylation Type | MAMMALIAN |
Glycosylation Link Type | Site |
---|---|
N | 1_296 |
N | 2_296 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
STARTING MATERIAL -> INGREDIENT | |||
|
TARGET->RADIOLIGAND |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY | |||
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|